Literature DB >> 9161310

Cost effectiveness of day and inpatient psychiatric treatment: results of a randomised controlled trial.

F Creed1, P Mbaya, S Lancashire, B Tomenson, B Williams, S Holme.   

Abstract

OBJECTIVE: To compare direct and indirect costs of day and inpatient treatment of acute psychiatric illness.
DESIGN: Randomised controlled trial with outcome and costs assessed over 12 months after the date of admission.
SETTING: Teaching hospital in an inner city area.
SUBJECTS: 179 patients with acute psychiatric illness referred for admission who were suitable for random allocation to day hospital or inpatient treatment. 77 (43%) patients had schizophrenia.
INTERVENTIONS: Routine inpatient or day hospital treatment. MAIN OUTCOME MEASURES: Direct and indirect costs over 12 months, clinical symptoms, social functioning, and burden on relatives over the follow up period.
RESULTS: Clinical and social outcomes were similar at 12 months, except that inpatients improved significantly faster than day patients and burden on relatives was significantly less in the day hospital group at one year. Median direct costs to the hospital were 1923 pounds (95% confidence interval 750 pounds to 3174 pounds) per patient less for day hospital treatment than inpatient treatment. Indirect costs were greater for day patients; when these were included, overall day hospital treatment was 2165 pounds cheaper than inpatient treatment (95% confidence interval of median difference 737 pounds to 3593 pounds). Including costs to informants when appropriate meant that day hospital treatment was 1994 pounds per patient cheaper (95% confidence interval 600 pounds to 3543 pounds).
CONCLUSIONS: Day patient treatment is cheaper for the 30-40% of potential admissions that can be treated in this way. Carers of day hospital patients may bear additional costs. Carers of all patients with acute psychiatric illness are often themselves severely distressed at the time of admission, but day hospital treatment leads to less burden on carers in the long term.

Entities:  

Mesh:

Year:  1997        PMID: 9161310      PMCID: PMC2126667          DOI: 10.1136/bmj.314.7091.1381

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  20 in total

Review 1.  How should cost data in pragmatic randomised trials be analysed?

Authors:  S G Thompson; J A Barber
Journal:  BMJ       Date:  2000-04-29

Review 2.  Psychosocial interventions for schizophrenia.

Authors:  C Adams; P Wilson; A M Bagnall
Journal:  Qual Health Care       Date:  2000-12

3.  Respiratory day hospital: a novel approach to acute respiratory care.

Authors:  K Schwartzman; G Duquette; M Zaoudé; M J Dion; M A Lagacé; J Poitras; M G Cosio
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

Review 4.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

5.  A comparison of psychiatric day hospitals in five European countries: implications of their diversity for day hospital research.

Authors:  Thomas W Kallert; Matthias Glöckner; Stefan Priebe; Jane Briscoe; Joanna Rymaszewska; Tomasz Adamowski; Petr Nawka; Helena Reguliova; Jirí Raboch; Andrea Howardova; Matthias Schützwohl
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-10       Impact factor: 4.328

6.  [Acute day hospital as a cost-effective alternative to inpatient therapy].

Authors:  Kunigunde Pausch; Carlos Nordt; Eva-Maria Pichler; Ingeborg Warnke; Erich Seifritz; Wolfram Kawohl
Journal:  Neuropsychiatr       Date:  2017-03-06

7.  Psychotherapy in a day clinic: results of a 1.5 year follow-up.

Authors:  Almut Zeeck; Armin Hartmann; Klaus Kuhn
Journal:  Psychiatr Q       Date:  2005

8.  Predictive factors of length of inpatient treatment in anorexia nervosa.

Authors:  Luisa Strik Lievers; Florence Curt; Jenny Wallier; Fabienne Perdereau; Zoé Rein; Philippe Jeammet; Nathalie Godart
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-09-22       Impact factor: 4.785

Review 9.  Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective.

Authors:  Mauro Percudani; Corrado Barbui; Michele Tansella
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  [Sociotherapy in German social law. Indication, contents, and aspects of public health].

Authors:  R-M Frieboes
Journal:  Nervenarzt       Date:  2003-06-13       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.